This inventor holds 1 USPTO granted patent. Top assignee: Flagship Biosciences, Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Erik Hagendorn and Automated Assessment of Celiac Disease
Introduction
Erik Hagendorn is an inventor based in Boulder, Colorado, whose patent work addresses automated analysis of small-intestine biopsy images for celiac disease assessment. He is associated with Flagship Biosciences, Inc.
Latest Patents
Hagendorn is named on one patent, Automated Methods for Assessment of Celiac Disease. The invention describes digital image-analysis methods for evaluating tissue morphometry in small-intestine biopsy samples. The process creates a binary mask of the tissue footprint, places virtual stereology probes on the image, and estimates the tissue specimen’s surface-area-to-volume ratio. That ratio can support diagnosis and help assess disease severity in patients diagnosed with celiac disease. Hagendorn’s reported patent portfolio includes 1 patent.
Career Highlights
His patent reflects an application of automated digital pathology to the evaluation of biopsy tissue. By quantifying tissue structure from digital images, the method aims to provide measurements that can inform celiac disease assessment.
Collaborations
The patent lists Steven J. Potts and Nathan T. Martin among Hagendorn’s coworkers. The available information identifies Hagendorn’s association with Flagship Biosciences, Inc., but does not specify the individual roles of these collaborators.
Conclusion
Erik Hagendorn’s patented work focuses on using digital image analysis and tissue morphometry to support the assessment of celiac disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile